Sintx Technologies, Inc.
$2.78
▼
-1.18%
2026-04-21 09:25:01
www.sintx.com
NCM: SINT
Explore Sintx Technologies, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$11.46 M
Current Price
$2.78
52W High / Low
$6.78 / $1.72
Stock P/E
—
Book Value
$0.74
Dividend Yield
—
ROCE
-185.71%
ROE
-3.04%
Face Value
—
EPS
$-6.16
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
32
Beta
0.66
Debt / Equity
110.92
Current Ratio
1.51
Quick Ratio
1.29
Forward P/E
-1.41
Price / Sales
10.85
Enterprise Value
$10.16 M
EV / EBITDA
-0.99
EV / Revenue
9.98
Rating
Strong Buy
Target Price
$10.25
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | PAVmed Inc. | $9.44 | 150.27 | $60.26 M | — | -89.22% | -32.34% | $28.44 / $6 | $10.01 |
| 2. | Senseonics Holdings, Inc. | $6.87 | — | $287.13 M | — | -67.05% | -1.68% | $15.74 / $5.25 | $1.48 |
| 3. | InMode Ltd. | $14.57 | 9.84 | $923.14 M | — | 12.27% | 13.53% | $16.74 / $12.72 | $10.78 |
| 4. | 20/20 Biolabs, Inc. | $1.71 | — | — | — | -253.94% | -5.03% | $50 / $1.51 | $0.01 |
| 5. | TriSalus Life Sciences, Inc. | $4.6 | — | $285.58 M | — | -113.07% | 131.29% | $7.95 / $3.42 | $-0.68 |
| 6. | Neogen Corporation | $9.63 | — | $2.08 B | — | -0.05% | -25.57% | $11.43 / $4.32 | $9.68 |
| 7. | Glaukos Corporation | $123.8 | — | $7.27 B | — | -25.2% | -26.38% | $130.23 / $73.16 | $11.41 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.19 M | 0.15 M | 0.1 M | 0.29 M | 0.19 M | — |
| Operating Profit | -2.32 M | -3.35 M | -2.67 M | -2.38 M | -1.59 M | — |
| Net Profit | -2.21 M | -3.54 M | -2.32 M | -2.29 M | -1.7 M | — |
| EPS in Rs | -0.54 | -0.86 | -0.56 | -0.56 | -0.41 | -6.96 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.73 M | 1.25 M | 1.23 M | 0.6 M |
| Operating Profit | -10.72 M | -9.04 M | -13.36 M | -11.34 M |
| Net Profit | -10.36 M | -11.02 M | -8.26 M | -12.04 M |
| EPS in Rs | -2.51 | -2.67 | -2 | -2.92 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 9.51 M | 9.41 M | 15.37 M | 15.77 M |
| Total Liabilities | 6.58 M | 5.52 M | 6.59 M | 10.07 M |
| Equity | 2.93 M | 3.89 M | 8.77 M | 5.7 M |
| Current Assets | 5.65 M | 4.52 M | 5.53 M | 7.21 M |
| Current Liabilities | 3.73 M | 1.98 M | 2.91 M | 8.08 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -8.57 M | -8.64 M | -14.12 M | -10.26 M |
| Investing CF | 0.91 M | -0.19 M | -0.5 M | -1.1 M |
| Financing CF | 8.2 M | 9.09 M | 11.71 M | 3.34 M |
| Free CF | -8.76 M | -9.33 M | -14.64 M | -11.67 M |
| Capex | -0.19 M | -0.69 M | -0.53 M | -1.41 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 1.63% | 103.99% | — | — |
| Earnings Growth % | -33.48% | 31.4% | — | — |
| Profit Margin % | -884.75% | -673.65% | -2003.16% | — |
| Operating Margin % | -725.36% | -1089.56% | -1886.02% | — |
| Gross Margin % | 34.91% | 36.05% | 55.91% | — |
| EBITDA Margin % | -771.35% | -538.34% | -1840.1% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2024-05-28 | 1:0.005 |
| 2022-12-20 | 1:0.01 |